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Abstract
The pathology of Type I Diabetes mellitus is characterized by a significant or
complete ablation of the insulin secreting p-cell population of the pancreas. The
loss of P-cell mass is mediated by apoptosis and it has been shown that the
enzyme caspase-3 plays a pivotal role in the execution of apoptosis. Imaging of
caspase-3 in live p-cells can provide a novel tool for exploring disease
progression in Type 1 diabetes. In this thesis I have validated the use of a
bioluminescent caspase-3 reporter for monitoring apoptosis induced by proinflammatory cytokines in a clonal rat derived P-cell line (INS-1/832/13). I have
shown that the caspase-3 reporter construct and imaging strategy can detect
changes in caspase-3 activity with high sensitivity and temporal resolution, and
that caspase-3 activity induced by cytokines is transient in nature.
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1 Introduction
Blood glucose levels are maintained by the pancreatic hormones insulin and
glucagon. Diabetes Mellitus is a chronic disease in which ability to regulate blood
glucose homeostasis is lost. The disease state in diabetes is characterized by an
absolute or relative deficiency in insulin secretion.

1.1 Pathology of Diabetes
There are predominantly two types of diabetes, Type 1 diabetes mellitus (T1DM)
and Type 2 diabetes mellitus (T2DM). Pathogenesis of T1DM and T2DM follows
different mechanisms, but ultimately they both result in a significant or complete
ablation of the insulin secreting beta-cell (P-cell) population. In the development
of T2DM, environmental factors play a strong role in individuals that are
genetically predisposed. The mechanism for T2DM pathology involves an
increase in insulin resistance of peripheral tissues that triggers more insulin
secretion from the pancreatic p-cells in order to compensate for aberrant insulin
responses peripherally. The constantly elevated secretion levels of insulin lead to
increased stress on the endoplasmic reticulum (ER) and mitochondria of the pcell, eventually resulting in P-cell failure and death by apoptosis1.
T1DM is an autoimmune condition in which an immune attack is launched
against the P-cells. Histological sections of rodent and human islets from affected
individuals show an infiltration of CD4+ T-helper cells, CD8+ cytotoxic T-cells,
macrophages and natural killer cells into the islet, a phenomenon called insulitis.
Within this lesion of insulitis a number of cytokines have been identified, the most
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important of which

are the

pro-inflammatory cytokines:

Tumor Necrosis

Factor(TNF)-a , Interferon (IFN)-y and Interleukin (IL)-1|3. Treatment of rat
insulinoma derived INS-1 cells, mouse derived NIT cells and primary islet
cultures with this combination of cytokines has been found to cause cell death by
apoptosis2'5. IL-1 (3 has been found to be the primary mediator of P-cell
dysfunction by selectively inhibiting insulin secretion6 and upregulating the
expression of Fas (CD95)7 The upregulation of Fas makes the cell more
susceptible to death receptor mediated apoptosis. IFN-y has not been found to
be toxic on its own. However, in combination with IL-1 (3 and/or TNF-a, IFN-y has
been shown to have profound effects on [3-cell biology and function2, 5.
Furthermore, IFN-y has been shown to potentiate the effects of IL-1 (3 through the
suppression of ER stress defence mechanisms2,8, and increase susceptibility to
TNF-a induced apoptosis9 by inhibition of NF-kB mediated anti-apoptotic
pathways. In combination all three cytokines cause significant toxicity.

1.1.1 Beta-cell Apoptosis
Apoptosis plays a pivotal role in the development of both variants of
diabetes. It appears to be the primary mechanism of cell death involved in the
loss of (3-cell mass. Apoptosis is a form of programmed cell death that occurs
throughout development and life. It is a highly conserved ATP-dependent
process by which a cell is systematically dismantled. The morphological
hallmarks of apoptosis include decreased cell size, abnormal cell shape and
nuclear fragmentation. Prior to the morphological transformation of the cell, a
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very specific set of biochemical changes occur. The process leading to apoptosis
involves 2 major pathways: an extrinsic pathway and an intrinsic pathway
illustrated in Figure 1-1.

Intrinsic Pathway

Extrinsic Pathway
IL-lß, IFN-y
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Figure 1-1: Schematic of apoptotic pathways showing that both extrinsic and intrinsic pathways
converge on the activation of caspase-3 that eventually leads to cell destruction. The extrinsic
pathway can be initiated by members of the tumor necrosis factor family and activates caspase-3
directly through the activation of caspase-8. The extrinsic pathway can indirectly activate the
intrinsic pathway by the truncation of Bid, leading to caspase-3 activation by both caspase-8 and
caspase-9. The intrinsic pathway is initiated by the proinflammatory cytokines IFN-y and IL-1 ß. In
the intrinsic pathway caspase-3 is activated following dephosphorylation of the pro-apoptotic Bcl2 protein BAD. BAD dephosphorylation enables the release of mitochondrial proteins into the
cytosol that cause the activation of caspase-9 and eventually caspase-3. When caspase-3 is
cleaved it can cleave a number of substrates including PARP and eventually lead to cell death.

Induction of both the intrinsic and extrinsic pathways causes the activation of a
family of proteolytic enzymes called caspases. The name caspase is derived
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from the words Cysteine ASPartic acid ProteASE. To date 14 mammalian
caspases have been discovered, and have been classified as initiator and
executioner caspases. The initiator caspases are characterized by the presence
of a larger regulatory domain which is involved in protein-protein interactions with
adaptor proteins and receptors10. A feature that is conserved between all
caspases is the presence of a large and small subunit. X-ray crystallography of
caspase-1 and caspase-3 showed that the active form of both enzymes requires
the formation of a heterodimer between large and small subunits; and the
heterodimers in turn form tetramers to become catalytically active11"13. Caspase-3
has been found to be central in the execution of apoptosis in many cell types.

1.1.2 Caspase-3 in Type 1 Diabetes Mellitus
Caspase-3 is classified as an executioner caspase and has a number of
substrates. Caspase-3 preferentially cleaves at the amino acid sequence
[DEVD|G], a sequence that was discovered to be a part of Poly ADP Ribose
Polymerase (PARP)10. The normal role of PARP is to repair DNA damage. Its
role in apoptosis, or more specifically, the importance of its cleavage by caspase3 is not clear. Boulares A.H et al14 have demonstrated that expression of a
caspase-3 resistant PARP or over expression of PARP advances apoptosis
much faster than in wild type cells14. The mechanism behind this acceleration
has not been thoroughly studied and may have interesting implications for
apoptosis drug design and therapies. Nevertheless, in the context of diabetes,
caspase-3 has been shown to play a critical role in (3-cell apoptosis, and appears
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to be a central mediator of T1DM pathology. Laidis et al15 have demonstrated the
importance of caspase-3-dependent apoptosis in the initiation of T1DM through a
genetic approach. Specifically, caspase-3'/_ and caspase-3+/+ mice were treated
with streptozotocin (STZ) to induce diabetes. The caspase-3/_ mice did not
develop diabetes, and there was no evidence of insulitis in their pancreata. Bone
marrow transplants from caspase-3+/+ mice did not cause insulitis in caspase-3_/'
mice suggesting that caspase-3 deficiency in immune cells was not responsible
for the lack of insulitis15. These results demonstrate the importance of caspase-3
in priming the immune system with (3-cell antigens.
The importance of caspase-3 has also been demonstrated in islet transplantation
protocols. It has been shown that treatment with the caspase-3 inhibitor Z-DEVDFMK immediately after islet isolation increased islet survival in a dose dependent
manner16. These islets also survived longer and resulted in prolonged glycémie
control over a 30 day period16. Another group demonstrated that administration of
pan caspase inhibitor Z-VAD-FMK to STZ treated mice for 5 days after
transplantation preserved islet function for as long as a year in comparison to
controls17. All in all the role of caspase-3 is extremely important in the
development of T1DM and determining islet survival. Monitoring caspase-3 in
living cells before the development of diabetes could provide more insight into
the pathology of T 1DM.
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1.1.3 Glucagon Like Peptide-1 & (3-cell apoptosis
A number of paracrine and endocrine factors contribute to (3-cell function and
survival. Among the endocrine factors is a hormone called Glucagon Like
Peptide (GLP)-1. GLP-1 is a 31 amino acid peptide produced in the L-cells of the
distal

ileum.

GLP-1

is derived

from

the post translational cleavage of

proglucagon, and is one of a number of potential products of proglucagon.
Processing

of proglucagon

into GLP-1

is mediated

by the prohormone

convertase (PC) 1/3 in endocrine cells18.
The primary trigger for GLP-1

secretion is the ingestion of food rich in

carbohydrates and fatty acids. GLP-1 is best known for inducing gluclose
dependent insulin secretion, while inhibiting glucagon secretion (incretin effect). It
has also been shown to play a role in (3-cell survival. Sherry et al19 and Yang et
al20 have demonstrated that in combination with immunomodulation, GLP-1
agonist exendin-4 was capable of reversing T1 DM in non obese diabetic (NOD)
mice19,20. Similarly expression of a GLP-1/lgG-Fc fusion protein has been shown
to protect against STZ induced (3-cell death and enhances (3-cell mass in diabetic
CD1 mice21. Wideman R. et al22 further demonstrated the positive effects that
endogenous GLP-1 expression has on islet function and survival, showing that
endogenous GLP-1 in islets improves insulin secretion, improves graft survival
and also protects the islets against IL-1 (3 induced toxicity22. In all three studies 13cell mass was shown to be enhanced after treatment with GLP-1/exendin-4 and
the p-cells were protected against injury. The mechanisms behind the positive
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effects on [3-cell survival have revealed a pleiotropic nature to enhancement of |3cell survival. Buteau et al have demonstrated that GLP-1 activates Phosphotidyl
lnositol-3 Kinase (PI3-K), increases DNA synthesis and pancreatic and duodenal
homeobox (PDX)-1 binding to DNA23. Similarly, Wang Q. et al24 has found that
GLP-1 regulates proliferation and apoptosis through the activation of Protein
Kinase B, a substrate of PI3-K. Treatment of INS-1 cells with GLP-1 significantly
increases cell survival when apoptosis is induced with staurosporine (STS), a
potent activator of apoptosis24. This effect is prevented by PI-3K inhibitor
wortmannin24. Activation of the PI3-K pathway is essential for the survival and
anti apoptotic effects of GLP-1, and has been found to occur through the trans
activation of the Epidermal Growth Factor receptor by the GLP-1 receptor25. The
more specific effects of GLP-1 on apoptosis have been elucidated by Li et al26. In
his study it was shown that P-cells treated with exendin-4, a GLP-1 receptor
agonist, were protected against cytokine induced apoptosis and that GLP-1
inhibits the release of cytochrome c into the cytosol after (3-cell injury26. The
release of cytochrome c is a critical step in the induction of intrinsic apoptosis
and caspase-3 activation. Li and colleagues26 further demonstrated a marked
decrease in the relative activities of caspase-8, caspase-9 as well as caspase326. Further solidifying the pleiotropic nature of GLP-1 action on apoptosis, Hui et
al27 have shown that GLP-1 inhibits apoptosis in a cyclic AMP (cAMP) dependent
Protein Kinase A and PI3-K dependent manner27. Co-treatment of the mouse
insulinoma derived MIN6 cells with GLP-1, and either PI3-K inhibitor LY294002
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or cAMP inhibitor Rp-cAMP, did not protect MIN6 cells from hydrogen peroxide
induced cell death, whereas co-treatment with GLP-1 and MAPK inhibitor
PD098059 protected the cells from apoptosis27. The results of these studies
demonstrate that the inhibition of caspase-3 activity by GLP-1 works through
both the intrinsic and extrinsic pathways.

1.2 Molecular Imaging of Apoptosis
In recent years imaging of P-cell mass has been an area of extensive research
because it can provide a non invasive method of quantifying p-cell mass and it
has the potential to detect changes in that mass before any symptoms become
apparent. There are two dominant strategies in molecular imaging, 1) using
exogenous contrast and 2) using endogenous contrast. Exogenous contrast
involves the introduction of a targeted contrast agent (probe) that can recognize
a molecule of interest, while endogenous contrast can be genetically encoded to
mirror the molecule of interest in expression or action (reporter). Each of these
methods has strengths and limitations. The greatest strength of a probe is that it
can be modified to work with multiple imaging modalities with more ease than a
reporter can be, and it is more applicable to in vivo imaging. The greatest
limitation of both targeted probes and intracellular reporters is that of clearance. If
a probe is not efficiently cleared, or the clearance organs are in close proximity to
the organ of interest, high background significantly degrades contrast to
background ratio. Because intracellular reporters are genetically encoded, they
are generally limited by the strength and specificity of their promoters, or the
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efficiency of the process they are responding to. The greatest strengths of a welldesigned reporter are the levels of tissue and cell specificity, and the ability to
report dynamic processes such as gene expression and enzyme activity.
In this laboratory, studies involving imaging of the GLP-1 receptor have
generated a number of targeted probes for in vivo imaging28. The present thesis
deals specifically with imaging the more dynamic processes that precede
changes in (3-cell mass and monitoring apoptosis in an in vitro system. The
complexity of apoptosis allows for a great number of imaging targets and events.
There have been a number of probes designed with the purpose of imaging
apoptosis. This section will outline some of the imaging targets that these probes
have been generated against and highlight some of the probes.
To date the most successful imaging probes have been Annexin V (A5) based
probes that are sensitive to late stages of apoptosis. The membrane lipids
phosphatidylserine

(PS)

and

phosphatidylethanolamine (PE) are

normally

expressed on the interior leaflet of the plasma membrane (PM). Towards the end
of apoptosis the inner and outer leaflets of the PM are rearranged, resulting in
the exposure of inner leaflet lipids (PS and PE) to the extra cellular matrix.
Annexin V labeled probes target PS and have been used extensively in flow
cytometry to detect apoptosis in cell populations. In 2005 a fluorescence probe
based on A5 labelling was generated for the imaging of apoptosis in diabetes
and was shown to successfully localize to apoptotic cells in mouse pancreata29.
Despite their success in imaging the pancreas, PM scrambling represents end
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stage apoptosis. This also provides very little information regarding cellular
function and limited temporal resolution for the internal events in the cell. Another
probe that takes advantage of the rearranging of the PM is a positron emission
tomography (PET) based probe, 18F-labeled-5-fluoropentyl-2-methyl-malonic acid
([18F] ML-10). [F18] ML-10 is an amphipathic small molecule that selectively enters
apoptotic cells after the PM is rearranged. A study published in 2008 evaluated the
performance of this probe as a PET reporter in an experimental cerebral stroke model
and successfully detected apoptosis in rat brains30. The limitations of this probe are
similar to those of A5 labeled probes in that they take advantage of more or less static
aspects of a dynamic process. As a result of these limitations, novel designs for
imaging probes and more complex and dynamic targets are required.
Imaging probes that detect earlier points in apoptosis include several small molecules for
Positron Emission Tomography (PET) and optical imaging. Intracellular, genetically
encoded reporters are better suited for capturing the dynamic nature of apoptosis
than extracellular, targeted probes. Changes in mitochondrial permeability
directly precede activation of the intrinsic caspase cascade and can be measured
in multiple ways. With the exception of cellular electrophysiology, the standards
for

measuring

changes

in

mitochondrial

permeability

are

fluorescent

mitochondrial dyes that include JC-1, CMXRos and DiOCe(3).
JC-1 (5,5’, 6,6’-tetrachloro-1,1,3,3’-tetraethylbenzimidazolylcarbocyanine iodide)
is a carbocyanine mitochondrial dye that reversibly transitions between green
and red fluorescence in a concentration dependent manner. The dye localizes to
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the intermembrane space of the mitochondria and forms what are known as Jaggregates at high concentrations. These J-aggregates fluoresce red with
emission at 590 nm, and upon mitochondrial membrane permeabilization, the
dye moves down its concentration gradient resulting in the dissociation of the Jaggregates and a transition to green fluorescence at 527 nm31. When compared
with DiOC6(3) and CMXRos, JC-1 is the only dye capable of detecting changes in
mitochondrial permeability, while all are capable of discerning cell viability32. JC-1
has been used extensively in flow cytometry, and has also been used to measure
changes in mitochondrial potential in individual mitochondria33. The Leow et al33
approach provides in situ measurement of mitochondrial potential, but requires a
complicated set up and highly sensitive instruments. As a result, a more general
method that takes advantage of the power of ratiometric normalization was
developed34, and this method has been adapted for use in INS-1 cells35.
Isatins are a class of small molecules that are competitive and reversible
inhibitors of caspase-3. To date, 3 isatin based probes have been generated with
varying success. Recently D.L Chen et al36 published a comparative study of the
efficiency of [ 11C] WC-98 and [18F] WC-IV-3 in detecting caspase-3 activity with
PET imaging36. In brief, Sprague Dawley rats were injected intravenously with
cyclohexamide, an inhibitor of protein synthesis and inducer of apoptosis, 3 h
before administration of the tracers. Micro PET images were taken using a 60
min dynamic scan. The imaging data showed that rats receiving [18F]WC-IV-3
accumulated the probe in the liver more so than those receiving [11C]WC-98.
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Biodistribution data showed significant accumulation of [18F]WC-IV-3 in several
tissues within 30 min and only in the liver after 60 min. In contrast, accumulation
of [11C]WC-98 in the liver was observed within 30 min36. This study does not
effectively demonstrate the efficacy of using isatin based probes for detecting
caspase-3 activity in vivo because they were not targeted to a specific tissue.
Accumulation in the liver is likely due to clearance of the probe, not apoptosis.
The PET based isatin probes described in this section may very well be excellent
probes in vivo. However, the comparative study in question did not effectively
show the probes ability to localize to apoptotic cells. Improving the experimental
design would more effectively test the true performance of the isatin based
probes. In order to better test their performance as detectors apoptosis, injection
of the isatin probes should follow the induction of apoptosis in a tissue that is
distant from the clearance organs. This would ensure that increases in probe
accumulation are in fact due to apoptosis and not clearance.
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Table 1: Targets and Targeting Molecules for Imaging Various Stages of
Apoptosis__________________________________________________________
Targeting
Stage in
Model
References
Target
Apoptosis
Molecule
Various
29
Late
Phosphatidylserine (PS) Annexin-V
Isatins:
W C-ll-89
Rat
36
Early
Caspase-3
WC-IV-3
WC-98
Plasma
Membrane
Permeability

ML-10

Late

Mouse

30.

Mitochondrial Membrane
Permeability

DÌOC6
JC-1
CMXRos

Early

Cell

32

1.2.1 Genetically Encoded Caspase-3 Reporters
The probes in Table 1, with the exception of the mitochondrial permeability
probes, are excellent for animal work because they can be injected and they
achieve good tissue penetration. All probes are subject to the same problems
when imaging the pancreas. Given the size of the pancreas and its proximity to
the liver and kidneys, the major clearance organs, isolating a specific signal that
can be resolved from the high background in the clearance organs is a major
challenge. In preclinical research, another way these issues can be resolved is to
use genetically encoded reporters. The advantage to using genetically encoded
reporters is that they can be targeted not only to a specific process, but also to a
specific cell type. Many genetically encoded reporters for apoptosis have now
been generated, including caspase-3 sensors designed for optical imaging
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(fluorescence,

Forster

Resonance

Energy

Transfer

(FRET),

and

bioluminescence).

1.2.2 Principles of Optical Imaging & Optical contrast agents
Optical imaging relies on the detection of photons that lie within the visual range
of the electromagnetic spectrum. These wavelengths range from 390 nm to 750
nm and correspond to blue and red light respectively. There are several detection
and image capture strategies in place for optical imaging. Microscopy is the most
commonly

used

optical

technique

and

it is primarily

used

to

capture

ultrastructural information at a subcellular level. With the use of novel fluorescent
probes and reporters, microscopy is also used for functional imaging at a cellular
level. Fluorescence is a molecular property that results in the emission of
photons after the

absorption

of energy. At a more fundamental

level,

fluorescence occurs when an orbital electron of an atom (fluorophore) absorbs
energy from a photon and rises to an excited energy state. When this electron
returns to its ground state energy, it emits a photon at a wavelength longer (lower
energy) than the one it absorbed. The amount of energy that can be absorbed by
the electron is discrete, and as a result, when the electron returns to ground state
the photon emitted will have a discrete and specific energy or wavelength.
Different fluorophores have specific emission spectra making them useful for
examining several different subcellular structures or processes simultaneously.
Bioluminescence is an optical property that results in the emission of photons
from a chemical reaction. This reaction is mediated by enzymes called
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luciferases that catalyze the metabolism of their substrates. In molecular biology,
two luciferases, (Sea pansy) Renilla reniformis luciferase (RLuc) and (firefly)
Photuris lucicrescens luciferase (Flue) are commonly used. Rluc is a 35 kDa
single chain polypeptide that metabolizes luciferin and has an emission spectrum
peak at 480 nm37.

Rluc is not typically used on its own in in vivo imaging

because of the propensity of biological tissues to absorb light in the Rluc
emission spectrum. In biological systems Rluc is typically coupled with a
fluorophore that has an emission spectrum better suited for tissue penetration in
a form of resonance energy transfer. Firefly luciferase is a 62 kDa single chain
polypeptide with an emission peak at 560 nm and a quantum yield of 0.88, the
highest of all known luciferases. Crystallography of Flue reveals that Flue folds
into two distinct domains, a large N terminal domain and a small C terminal
domain that are separated by a wide, flexible cleft38. The active site of the
enzyme is formed by the N terminus and C terminus sandwiching the substrates,
and creating a favorable environment for the light reaction to occur38. The light
reaction of luciferase requires ATP and molecular oxygen. D-luciferin and ATP
enter the active site of luciferase and form a high energy intermediate. Oxygen is
then incorporated into the substrate, and the energy from the intermediate is
released as a photon. The resulting products are oxyluciferin and a photon
(Reaction illustrated in Figure 1-2).
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Luciferin

Reaction 2

Oxyludferin

+ Photons + C 02 + H20

Figure 1-2: Schematic of Firefly Luciferase light reaction. D-Luciferin in the presence of
Luciferase ATP and Oxygen is metabolized into Oxyluciferin by a two step process that results in
the emission of photons, C 0 2, inorganic phosphates, AMP and H20.

1.2.3 Fluorescence and Forster Resonance Energy Transfer based
Caspase-3 Reporters
Fluorescence reporters, such as the Green, Red and Yellow Fluorescent proteins
(GFP, RFP & YFP) have been used extensively for imaging. In recent studies, a
strategy

for

detecting

caspase-3

activity

with

fluorescence,

outside

of

multimodality reporters, has relied on the localization of the fluorophore to detect
activation. In 2008 the reporter Apoliner was generated and characterized by
Bardet P.L et al39. The approach of this study involved a combination of
enhanced GFP and mRFP that were linked to a nuclear localization signal (NLS)
and a transmembrane protein fragment respectively. The two chimeric proteins
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were then linked by a caspase cleavage site. In the event of caspase-3
activation, the reporter would be cleaved, releasing eGFP-NLS and allowing that
protein to accumulate in the nucleus. This reporter was shown to successfully
respond to caspase-3 activation in living dMP2 embryonic neurons and in the
epidermis of developing Drosophila embryos in a time dependent manner,
achieving temporal resolution on the order of minutes39. While this reporter is
promising, the cleavage of the reporter is not reversible; also, like all fluorescent
probes, it is susceptible to auto fluorescence. A similar reporter that takes
advantage of a NLS was published in 2007 by Golbs et al40. This reporter, like
Apoliner has the strength of high spatial and temporal resolution, but is subject to
the same limitations.
Förster resonance energy transfer (FRET) is a phenomenon that was initially
described by Förster in 1948 where energy is transferred from a donor
fluorophore to a recipient fluorophore in a non radiative manner. This
phenomenon occurs at a critical proximity of the fluorophores to each other,
known as the Förster distance. Upon energy transfer, the donor returns to its
ground state, and the recipient absorbs the energy in discrete packets, and
returns to its ground state by emitting a photon. Since FRET depends on
fluorophore proximity, it is an excellent tool with which to report protein-protein
interactions, and has been used more recently in protease reporter design. In
1998 X. Xu et al41 described a caspase-3 FRET reporter containing eGFP and
enhanced Blue Fluorescent Protein (eBFP). It was hypothesized that linking
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these two proteins with a short peptide sequence containing the DEVD sequence
would result in a FRET signal from eGFP that would be abrogated by the
cleavage of that sequence by caspase-3. Reporter activity in response to
caspase-3 was detected through Fluorescence Activated Cell Sorting (FACS), a
form of flow cytometry41. This report demonstrated a proof of principle, and
several variations on this reporter have since been generated. Most notably the
same group made a reporter capable of simultaneously detecting caspase-3 and
caspase-6 activity42 and Bioluminescence Resonance Energy Transfer (BRET)
reporters43. The BRET reporters work by using Renilla luciferase as the energy
donor and GFP and YFP as recipients with slight differences in spectral emission
and BRET efficiencies44. A great advantage of this method is that it is more
sensitive than FRET and eliminates the need for an exciting laser to induce
fluorescence. The increase in sensitivity results from the absence of tissue
autofluorescence.

1.2.4 Firefly Luciferase Caspase-3 Reporters
To date there are 5 FLuc based caspase-3 reporters. At the time this work began
there were 4, each employing different methods of quenching FLuc activity. The
first generation was generated in 2002 by Laxman et.al45 and used the estrogen
receptor (ER) sequence to attenuate Flue through steric interactions45. Two
variants of this reporter were generated; one containing only one copy of the ER
sequence linked to the carboxy terminus of Flue by a linker containing the
caspase-3 cleavage sequence DEVD (ER-DEVD-Fluc); and one with two ER
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sequences on the amino and carboxy termini, respectively (ER-DEVD-FlucDEVD-ER). Each of the linkers contained the caspase-3 cleavage recognition
sequence DEVD. ER-DEVD-FLuc was shown to achieve a 50% attenuation of
Flue activity, while ER-DEVD-Fluc-DEVD-ER almost completely abolished Flue
activity in comparison to native luciferase. Treatment of D54 glioma cells with
TNF-a Related Apoptosis Inducing Ligand (TRAIL) showed a dose-dependent
response of ER-DEVD-Fluc-DEVD-ER, with more efficient cleavage at higher
doses. Athymic nude mice bearing tumors expressing ER-DEVD-Fluc-DEVD-ER
showed a 3-fold increase in luciferase activity when administered TRAIL
intratumorally45. Although this method produced promising results there are a
number of drawbacks to this technique, most notably that cleavage of ER-DEVDFLuc-DEVD-ER into free luciferase at low TRAIL doses is very inefficient and
only results in a fraction of the potential signal.
In 2007 a cyclic luciferase reporter was generated by Kanno et al46. This reporter
silences Flue activity by fusing the N and C ends of the enzyme. Digestion by
caspase-3 linearizes the reporter and is sensitive enough to detect basal levels
of caspase-3 activity that are reduced by the pan caspase inhibitor Z-VAD FMK.
High doses of STS were shown to cause up to an 8 fold increase in luciferase
activity in COS-7 cells transfected with the reporter46. Reporter activation was
transient in nature, peaking at 3 h of STS treatment. This group was the first to
demonstrate a window of activity for caspase-3 enzymatic activity that is transient
in nature.
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In 2008 luciferase-based caspase-3 reporters were generated by two groups. One
was a tri-fusion multimodality reporter, designed to silence luciferase activity
using a strategy similar to that used by Laxman et al45. The trifusion reporter
combines fluorescence imaging, bioluminescence imaging and positron emission
tomography by fusing the coding sequences for RFP, Flue and thymidine kinase
(TK) separated by linkers containing the caspase-3 cleavage site. Each of the
reporter modalities serves the same role as the ER does in Laxman et al’s45
reporter, causing silencing of all 3 reporters’ activities by steric interactions. The
trifusion reporter has the same limitations as the ER-DEVD-Fluc-DEVD-ER
reporter in that the activity of FLuc, TK and RFP cannot be fully restored,
resulting in decreased sensitivity for each imaging modality47.
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Figure 1-3: Schematic Illustrating the construct layout of the 4 FLuc reporters. Construct 1, ERDEVD-FLuc-DEVD-ER silences FLuc activity by linking ER to the N and C termini of FLuc.
Construct 2 uses the same strategy to silence FLuc, but instead of ER, RPF and TK are used
attached to the N and C termini. Construct 3 is a cyclic reporter linking the N and C termini to
each other through a short linker sequence containing the DEVD sequence. Construct 4
separates the N and C termini of FLuc from each other with 2 peptides, PepA and PepB, and a
linker region containing the DEVD sequence. Cleavage of all 4 reporters at the DEVD sequence
by caspase-3 restores FLuc activity.

The caspase-3 reporter used in the present study is illustrated in Figure 1-3 (4)
and in more detail in Figure 1-4. It utilizes the principle of split luciferase
complementation that was first demonstrated by Kanno A et.al48 in order to
detect translocation of mitochondrial proteins into the cytosol48. The N-teminal
and C terminal sequences of luciferase have been inserted into the construct
such that the orientation of the N-terminal subunit of the enzyme is in the reverse
orientation, rendering the enzyme inactive without cleavage. The N and C
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terminal subunits are then fused to two peptides, PepA and PepB49 respectively,
with a high binding affinity for one another and joined by a linker region
containing the caspase-3 cleavage site. When caspase-3 is active, the reporter is
cleaved at the DEVD sequence. After cleavage PepA and PepB bind to each
other bringing the N and C terminal ends together and restoring enzyme function.
The construct design and mode of action are illustrated in Figure 1-4.

Caspase-3
PepA

DEVD -mmmmm. pepB

fidusiism
PpnA
PepB

Light P hotons
M e ta b o lite s

Figure 1-4: Schematic of ANLucBCLuc Activity In response to Caspase-3 Cleavage. 1) Caspase3 cleaves ANLucBCLuc at the DEVD site. 2) ANLuc and BCLuc with the help of Pep A and Pep B
form functional Flue and in the presence of ATP and D-Luciferin carries out the light reaction. 3)
Light is emitted from the reaction and the metabolites (oxyluciferin) are released.

The developers of this construct found that treatment of mice bearing D54 glioma
tumors with temozolomide, a DNA alkylation and méthylation agent for glioma
treatment, showed a time and dose-dependent increase in bioluminescence that
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peaked 3 h after treatment. In the validation of the construct, Western blot
analysis for FLuc showed 2 bands corresponding to ANLuc and BCLuc as a
result of cleavage of the reporter after 3 h of treatment of D54 glioma cells with
100 nM staurosporine50. This construct is well characterized and it is for this
reason that it was chosen for this work.

1.3 Rationale
As previously mentioned, cytokines appear to play a critical role in the
development of T1DM. In 2003, a microarray study was conducted on INS-1 E
cells after 1, 2, 4, 6, 8, 12, and 24 h of treatment with IL-1(3 and IFN-y to
investigate gene networks that are regulated by pro-inflammatory cytokines3. The
study revealed a number of gene networks that are regulated by this cytokine
mixture. The most interesting findings with respect to apoptosis are the changes
in the apoptotic proteins BAD and caspase-3. Within 2 h of cytokine treatment,
mRNA expression of BAD and caspase-3 increases, then returns to baseline at 4
h and 8 h respectively3. These findings illustrate the highly dynamic nature of
apoptosis, but the results focus on the level of gene expression rather than
protein modification and enzymatic activity. Apoptotic proteins are regulated
through protein modifications and enzymatic action. Further study of caspase-3
at early time points has been carried out using traditional biochemical
techniques, fluorometric and bioluminescence assays51"53. The greatest limitation
of these studies is that they track changes in enzymatic activity in cell lysates
collected at set time points. These methods of measurement are static in nature,
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and more importantly may not be reflective of enzymatic kinetics but instead
measurements of accumulation. Therefore, new techniques and methods have to
be developed to reliably measure cytokine induced caspase-3 activity in a live
cell model.

1.4

Objectives

The objectives of this thesis are two-fold:
I.

To characterise and validate the use of ANLucBCLuc (caspase-3 reporter)
as a reliable apoptosis sensor in an in vitro T1DM cell model.

II.

To use the caspase-3 reporter in elucidating the mechanisms of caspase3 activation in response to cytokines.
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2

Materials & Methods

2.1 Materials
2.1.1 Cell Model: INS-1/832/13
The clonal cell line INS-1/832/13 was chosen for experiments. This INS-1 clone
was derived from the parental INS-1 cell line and has been engineered to stably
express human proinsulin. The insulin secretion and glucose response properties
are very similar to primary (3-cells in culture, and more specifically, both
potassium channel-dependent and independent insulin secretion are present in
this clone54.

2.1.2 Glucagon-Like Peptide 1 (GLP-1)
Glucagon-Like Peptide 1 is secreted in response to food ingestion and results in
slowing of gastric emptying, stimulation of glucose-dependent insulin secretion
and overall appetite control. Additionally, as discussed in Section 1.1.3, GLP-1
has been found to promote (3-cell survival and inhibit caspase-3 activity.
Given the short plasma half-life of GLP-1, exendin-4, a GLP-1 receptor agonist
isolated from the saliva of the Heloderma spp. with 53% homology to GLP-1 and
longer plasma stability has been chosen as an inhibitor of apoptosis in selected
experiments.

2.1.3 General Electric Explore Optix Imaging System
The imaging system used is a GE ExplorOpitx (General Electric) black box that is
equipped for live animal bioluminescence and fluorescence. The image capture
device relies on a set of photomultiplier tubes that register every photon count as
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a voltage, and raster scans a region of interest with integration times from 0.5-1 s
and step sizes 1-3 mm. For large regions of interest this can result in long scan
times. The advantage to this method over a cooled charge coupled device (CCD)
camera is that it does not need to be cooled to -70°C in order to have sufficient
signal over background.

2.2 Methods:
2.2.1 Cell Culture
The clonal rat P-cell line INS-1/832/13 (gift from Dr. Chris Newgard, Duke
University) was cultured at a 37°C in a humidified incubator containing 5% CO 2
and 95% air. The cells were grown in RPMI-1640 medium (Invitrogen)
supplemented with 10% FBS (Invitrogen), 50 pM 2-mercaptoethanol (Fisher),
500 mg/L sodium bicarbonate (Fisher), 110 mg/L sodium pyruvate (Invitrogen),
and 2.383 g/L HEPES (Fisher) as described by Hoheimer et al54. Cells were
passaged every 3 days and discarded after 30 passages. In order to passage the
cells, the medum was aspirated followed by a wash in 37°C Hanks Balanced Salt
Solution (HBSS) (Fisher). After the wash, 0.05% Trypsin (GIBCO) was applied to
the cells for 30 s, aspirated and the cells were allowed to sit for 1-2 min. The cells
were resuspended in 5ml RPMI-1640 and centrifuged at 800 G. The supernatant
was discarded and the pellet was resuspended then plated 1:10 in 75 mL culture
flasks (Falcon).
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2.2.2 Collecting Cell Lysates for Western Blotting
INS-1 cells were plated in 6-well dishes at 1x106 cells per well and were
administered their respective treatments after 24 h. Cells were washed twice with
ice-cold HBSS (Fisher), then collected in 100 pL Tris-EDTA lysis buffer
containing mini-complete protease inhibitors (Fisher) or 300 pL PhosphoSAFE
lysis buffer (Merck Chemicals). Protein content in cell lysates was quantified by
the colorimetric bicinchoninic Acid Assay (BCA Assay, Pierce Thermo Scientific).
In 96-well plates, protein samples were diluted 1:2 and 1:5 in lysis buffer to a
volume of 10 pL. The working reagent was prepared according to manufacturer’s
instructions, added to the protein samples and allowed to incubate for 30 min at
37°C. The resulting colour change was measured in a plate reader by taking
absorbance values at 575 nm, and was compared to a known protein standard to
determine concentration (25-2000 pg/ml).

2.2.3 Transfection Efficiency
In order to assess transfection efficiency, INS-1 cells were plated in a 35 mm
dish and transfected with eGFP using Lipofectamine 2000 (Invitrogen) according
to the manufacturer protocol. After 48 h the cells were trypsinzed and
resuspended in 500 pL RPMI-1640 without phenol red (Invitrogen) in preparation
for flow cytometry. Untransfected cells were passed through a flow cytometer in
order to distinguish between INS-1 cells and debris. Once the size and object
complexity

boundaries were

established

(forward

and

side scatter),

the

transfected cells were passed through the flow cytometer, and measured for GFP
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fluorescence. A total of 10,000 events were counted for Control and eGFP, and a
percentage of GFP positive cells was calculated for each group.

2.3 Bioluminescence Imaging
INS-1 cells were plated in a 24 well plate at 2.5x105 cells per well and transfected
with the bioluminescent caspase-3 reporter (gift from Dr. Alnawaz Rehemtulla,
Univeristy of Michigan) described in the introduction section 1.2.4 using
Lipofectamine 2000 as per manufacturer’s instructions. After 24 h, the media
were changed and following another 24 h the cells were prepared for imaging.
Immediately before imaging, cells were treated with 10 ng/ml IFN-y, 10 ng/ml IL1(3 and 50 ng/ml TNF-a (Sigma). The cells were imaged in a General Electric
Healthcare Explore Optix optical scanner every 2 h for 6 h (N=5). Fresh firefly Dluciferin (Xenogen) was added to the wells at a final concentration of 150 pg/ml
at each time point. The optical scanner collected data over the region of interest
at a rate of 1 mm/s with a 1 s integration time, and obtained a photon count at
each point. Photon counts are registered with a photomultiplier tube that
amplifies a single photon collision into a voltage. The scanner software then
forms an intensity colour map that is representative of the photon flux over the
area scanned. The data were normalized to the baseline image and presented as
bioluminescence (x baseline) vs Time (Mean ± SEM). For statistical analysis, a
conservative approach was used in order to minimize the chances of Type I
error. A 2-factor Analysis of Variance with Bonferroni correction (a=0.05) was
performed with pairwise comparisons for time and group (control/cytokines).
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2.3.1 Pulse Chase: Effects of temporary inflammation on caspase-3
In order to determine the short-term effects on caspase-3 after removal of
cytokines, INS-1/832/13 cells were incubated in 10 ng/ml IFN-y, 10 ng/ml IL-1(3
and 50 ng/ml TNF-a for 1 h following a baseline image. The media were changed
without a wash and the cells were imaged 0 h and 3 h after cytokine removal
(N=4). Bioluminescent images were analyzed using the GE Optiview software
native to the scanner. The data were normalized to the baseline image and
presented as bioluminescence (x baseline) vs Time (Mean ± SEM). These data
were analyzed by One-Way ANOVA and post hoc Tukey test with significance
set at 0.05.

2.3.2 Bioluminescence imaging with Exendin-4
In order to determine how GLP-1 affects early caspase-3 activation in INS-1
cells, cells transfected with ANLucBCLuc were pre-incubated overnight in 20 nM
exendin-4 (Bachem), a GLP-1 analogue found in Heloderma spp. The cells were
then treated with 10 ng/ml IFN-y, 10 ng/ml IL-1 (3 and 50 ng/ml TNF-a and imaged
every 2 h for 6 h (N=4). Bioluminescent images were analyzed using the GE
Optiview software native to the scanner. For each experiment, an average
photon count over 4 wells in a 24 well plate was taken for each time point. These
results were normalized to the baseline image and a global mean was calculated
for all treatments. The results were plotted as Bioluminescence vs. Time (Mean ±
SEM). These data were analyzed by Univariate ANOVA and post hoc Tukey
tests with significance set at 0.05.
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2.3.3 Examining the Roles of Intrinsic & Extrinsic Apoptotic
Pathways in Early Caspase-3 Activation
The combination of proinflammatory cytokines used in the experiments described
above reliably induces apoptosis. The combination works through both the
intrinsic and extrinsic apoptotic pathways. More specifically, TNF-a induces cell
death mediated by the extrinsic pathway, and both IL-1(3 and IFN-y work through
the intrinsic pathway. In order to determine the role that each pathway plays in
the early activation of caspase-3, transfected INS-1 cells were treated with either
10 ng/ml IFN-y and 10 ng/ml IL -ip or 50 ng/ml TNF-a. The cells were then
imaged every 2 h for 4 h (N=3). Results were analyzed by 2-factor ANOVA with
post hoc Tukey’s Test when significance was found.

2.4 Western Blots
2.4.1 BAD
Cell lysate protein, 50 pg, collected after 0, 2 and 4 h of cytokine treatment in the
absensce or presence of exendin-4 were separated by 12% SDS-PAGE. The
protein was dry transferred onto nitrocellulose membranes using the Invitrogen
dry transfer apparatus. The membranes were stained with Ponceau S diluted
1:1000 in 5% acetic acid to ensure equal loading, even migration and protein
integrity before blocking with 5% Bovine Serum Albumin (BSA, Fisher Scientific).
The primary antibody for BAD (Cell Signaling) was concentrated 1:1000 in 5%
BSA.
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2.4.2 Caspase-3 & 9
Cell lysates were collected after 0, 2 and 4 h of treatment with cytokines (TNF-a,
IFN-y, IL-1|3) in the absence or presence of exendin-4 and 50 pg of protein were
loaded into each well and separated by 10% SDS-PAGE. The blots were blocked
in 5% non-fat dry milk (casein protein) + Tris Buffered Saline with 0.05%Tween20 (TBS-T, Fisher) then incubated at 4°C overnight in (1:1000) rat a-rabbit full
length caspase-3 and rat a-mouse cleaved caspase-9 (Cell Signaling) antibodies.

2.4.3 Firefly Luciferase
Cell lysate protein, 20 pg, collected at 0 h, 0.5h and 2 h of cytokine treatment
were separated by 8% SDS-PAGE. The blot was blocked in 5% non-fat milk in
0.05% TBS-T and probed overnight at 4°C with a-luciferase antibody (Cell
Signaling) 1:10,000. Secondary antibody was applied at a concentration of
1:10,000 according to the protocol described in 2.4.4.

2.4.4 Secondary Antibody
After removing the solution containing the primary antibodies, the blots were
washed 3 times for 5 min with TBS-T and once with TBS to discard any unbound
primary antibody. The blots were then incubated in either anti-rabbit or anti
mouse Horse Radish Peroxidase (HRP) (1:5000) for 1 h at room temperature.
The blots were washed twice for 5-10 min in TBS-T and once in TBS before
incubating for 5min in Super Signal (Pierce). The blots were visualized using
GeneSnap software for the SynGene Chemiluminescence Documentation

32

System. Images of the blots were captured in GeneSnap and then analyzed in
GeneTools (SynGENE).

2.4.5 Densitometry Analysis
The GeneTools software generates a histogram for each band on the
nitrocellulose membrane. In order to determine the density of the bands, the area
under the peaks of the bands corresponding to the cleaved forms of caspase-3
and 9 were compared to those of the full length product at each time point as a
ratio of cleaved caspase: uncleaved caspase. The results were plotted as an
intensity vs. time graph (N=3) (Mean ± SEM). BAD was normalized to P-actin
loading control.

2.5 Im m u n o c y to c h e m is try
INS-1 cells were lightly plated on a cover slip (~50-60% confluent), fixed and
made permeable in 2% paraformaldehyde and 0.25% Triton-X-100 solutions in
Phosphate Buffered Saline (PBS) (Fisher) respectively. They were incubated
overnight with rat a-rabbit cleaved Poly Adenosine Ribose Polymerase-1 (PARP)
(1:100) primary antibody at 4°C. The Alexa 594 labelled secondary antibody was
applied (1:500) for 1 h and then incubated in Hoescht 33342 (Sigma) 1:5000 for
5 min in order to stain the nuclei then the cover slips were fixed to slides.
Ten randomly selected fields of view were taken from three slides for each
treatment. All images were taken at 400X total magnification through the DAPI
(blue) and TRITC (red) channels on an Olympus 1X81 microscope. The images
were then pseudo-coloured and overlaid in Adobe Photoshop. In order to define
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PARP-positive nuclei, cells in which both TRITC and DAPI nuclear staining were
co-localized were counted. One hundred nuclei were randomly counted in 10
fields of view for each treatment, and PARP-positive nuclei were taken as a
percentage of the total number of nuclei. The data were analyzed by 2 factor
ANOVA with Group and Time as the factors and were followed by post hoc
Tukey’s tests.

2.6 Fluorescence Imaging (Live Cells)
2.6.1 Mitochondrial Membrane Permeability
The mitochondrial dye JC-1 is taken up by the mitochondria and forms Jaggregates that fluoresce red. When the mitochondria are damaged they
become ‘leaky’ resulting in JC-1 flowing down the concentration gradient into the
cytosol. At the low concentrations found in the cytosol, JC-1 returns to the
monomeric form that fluoresces green. In order to investigate how cytokines
affect mitochondrial membrane permeability, a change that occurs prior to
caspase-3 activation by the intrinsic apoptotic pathway, 4 types of experiments
were conducted. INS-1 cells were incubated in 25 nM JC-1 (Invitrogen) for 1 h35.
The media were removed and replaced without rinsing. Cells were treated with
vehicle, 10 ng/ml IFN-y, 10 ng/ml IL-1(3 and 50 ng/ml TNF-a, 10 ng/ml IFN-y and
10 ng/ml IL-1 (3 or 50 ng/ml TNF-a and images were collected every 20 min for 4
h on an Olympus 1X81 microscope equipped for live cell imaging with TRITC and
FITC filters (Alexa 594 and Alexa 488). The Alexa 594 channel was set to a gain
and exposure time such that the signal was as high as possible before pixel
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saturation in the camera. The Alexa 488 channel was set such that the total
fluorescence on the first image was approximately equal to that of the Alexa 594
channel. A ratio of green fluorescence (Alexa 488) to red fluorescence (Alexa
594) was taken at each time point and normalized to the first image to yield a
percent change in fluorescence (N=3). These results were analyzed by 2-Factor
Repeated Measures ANOVA with 13 levels at a significance of 0.05. The time
curves were integrated to yield and area under the curve (AUC) for each
treatment. The AUC data were analyzed by Kruskal Wallis Test, a nonparametric
statistical analysis of variance due to small sample size and unequal variances
between groups.

2 .7 Im a g e A n a ly s is
F luorescence im ages were analyzed in Image J 1.40g. Measurements of
integrated density (total fluorescence) in Alexa 594 and Alexa 488 images were
taken for each time point. A ratio of Alexa 488 to Alexa 594 values was taken and
was normalized to total fluorescence at time zero (T0=1). Results were reported
as Fluorescence vs. Time graphs (Mean ± SEM).

2 .8 D N A F ra g m e n ta tio n A s s a y
DNA fragmentation is an important end stage marker of apoptosis. INS-1 cells
were plated at an area density of 1x106 per each well of a 6 well dish and
received treatments of 10 ng/ml IFN-y, IL-1J3 10 ng/ml and TNF-a 50 ng/ml for 24
h or 10 ng/ml IFN-y and 10 ng/ml IL-1 (3 or 50 ng/ml TNF-a for 24 h.Cells were
trypsinized according to the protocol previously described then the cells were

35

lysed and collected in incubation buffer provided in the Cell Death Detection Kit
(Roche). The cell lysate was spun for 15 min at 16,000 G in order to separate
fragmented DNA from the larger cell components and the supernatant was
placed in a fresh tube. An aliquot of 100 pL was taken from each sample for
protein quantification by BCA Assay as described in 2.2.2. The wells of a 96 well
plate were coated with a coating solution containing anti-histone antibodies for 90
min then washed 3 times with the washing buffer provided in the kit. After
washing the wells, 100 pL of sample was added to each well and allowed to
incubate for 90 min. The wells were washed 3 times and then conjugate solution
containing anti-DNA antibody and were added to each well for 90 min. The wells
were washed 3 times then the substrate solution was applied to each well and
shaken at 225 RPM for 15 min. Absorbance readings were taken at 405 nm and
each reading was normalized to the protein concentration of each sample. The
results were presented as 3 graphs, Absorbance/pg protein vs Treatment,
Protein concentration vs Treatment and Absorbance vs Treatment (Mean ± SEM)
(N=3). The results were analyzed by One-Way ANOVA with post hoc Tukey tests
when significance (a=0.05) was found. The protein data and DNA data were
analyzed individually by One-Way ANOVA. The protein data failed Levene’s test
of homogeneity of variance and were therefore analyzed by Kruskal Wallis test.

2 .9 S ta tis tic a l A n a ly s is
All Statistical analysis was done using the PAWS 18 Statistical Package.
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3

Results

I conducted all experiments herein, with the exception of the Western blot in
Figure 3-2 which was done by Rebecca McGirr, research technician.

3 .1 IN S -1 /8 3 2 /1 3 T ra n s fe c tio n E ffic ie n c y
In order to quantitatively assess the level of transfection, INS-1/832/13 cells
transfected with eGFP were trypsinized and counted by flow cytometry. Based on
forward and side scatter profiles, objects contained by the pink boxes in Figure 21 panels A and C were defined as cells and counted for GPF fluorescence. This
experiment revealed a level of transfection at 25.5% (Figure 3-1D). Additionally,
the wide range of GFP intensities indicates that the level of expression is variable
(Figure3-1D).
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Figure 3-1: Quantitative Assessment of Transfection Efficiency. Objects within the pink boxes A,C
were defined as cells. Quantification of GFP positive cells showed 0.043% GFP positive in
untransfected cells (B) and 25.5% in transfected cells (D). There is a wide range of GFP
intensities in the GFP positive cells.
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3 .2 E x p re s s io n a n d V a lid a tio n o f th e C a s p a s e -3 L u c ife ra s e
R e p o r te r
Pro inflammatory cytokines have been shown to cause significant apoptosis in 13cell models.

INS-1 cells transfected with ANLucBCLuc were treated with the

proinflammatory cytokine cocktail described in the Methods section (IFN-y, IL-1(3
and TNF-a). In order to ensure that the ANLucBCLuc protein was being cleaved,
qualitative Western

blot analysis

on

lysates from

cells transfected with

ANLucBCLuc and treated with cytokines for 0, 0.5 and 2 h showed that the
construct was cleaved at 2 h of treatment. Two bands corresponding to the
BCLuc fragment (22Kda) and the ANLuc fragment (47Kda) were evident at 2 h
post-treatment (Figure 3-2).

Oh

0.5h

2h

ANLucBCLuc69 kDa

ANLuc47 kDa

BCLuc 22kDa

Figure 3-2: Confirmation of reporter cleavage by Western blot: Bands correspond to luciferase
expression of cell lysates collected at 0 h, 0.5h and 2 h of cytokine treatment. After 2 h of cytokine
treatment, bands corresponding to the cleaved fragments of the luciferase reporter are apparent.
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Once cleavage of the reporter was confirmed by Western blot, transfected INS-1
cells were treated with the cytokine mixture and images were taken every 2 h
until 6 h. Figure 3-3A shows representative images taken at 0-6 h in control and
cytokine

treated

cells.

Cytokine

treatment

resulted

in

an

increase

in

bioluminescence that peaked at 4 h and began to drop at 6 h. Quantification of
the bioluminescence results illustrated in Figure 3-2B showed an increase that
peaked at 4 h then returned to baseline by 12 h. Bioluminescence in the cytokine
treated group was significantly different from the control group (p<0.05) and the
effect was seen at 4 h of treatment (p<0.05).
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Figure 3-3: Live Imaging of Caspase-3 In Response to Cytokines.(A) Raw images of Control and
Cytokine treated INS-1 cells from 0-6 h. Colour bar represents photon counts/s. Increase in
bioluminescence begins at 2 h of cytokine treatment peaking at 4 h and beginning to decrease at
6 h. (B)Quantification of bioluminescence from live cell imaging is representative of 5 independent
experiments presented as mean ± SEM. There is a peak in bioluminescence at 4 h (p<0.05) with
cytokine treatment.

3 .3

P u ls e C h a s e : E ffe c ts o f tra n s ie n t in fla m m a tio n o n c a s p a s e -3
a c tiv ity

The effects of an acute cytokine insult were explored through a pulse chase
experiment. After a baseline image had been acquired, cells were treated with a
1 h pulse of cytokines and imaged immediately after and 3h following the pulse.
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The imaging results were analyzed by one way ANOVA. Immediately after the
pulse, there was no change in bioluminescence (p<0.05) but at 4 h there was a
significant increase (p<0.05) in bioluminescence.

Counts

1h Cytokine Pulse
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0

Baseline

Oh post pulse

3h post pulse

Figure 3-4: Live Cell imaging of the Effects of a Short Cytokine Pulse. The images are
representative images of the baseline, 0 h after a 1 h cytokine pulse and 3 h after the cytokine
pulse. Colour bar represents photon counts/s. The caspase-3 reporter is activated 3 h after the
cytokine pulse. The graph is a quantification of the pulse chase images. Bars represent mean ±
SEM of 4 independent experiments. There was a significant increase in bioluminescence three
hours after the removal of cytokines (p<0.01).

3 .4

E ffe c ts o f E x e n d in -4 /G L P -1 o n c y to k in e In d u c e d A p o p to s is

GLP-1 and exendin-4 are known to promote glucose-dependent insulin secretion,
and inhibit apoptosis in (3-cells. In order to determine the effects of exendin-4 on
caspase-3 activity in real time, bioluminescence imaging was carried out on INS1/832/13 cells that were treated with cytokines either in the absence or presence
of 10 nM exendin-4. There was a significant increase in bioluminescence in the
cytokine treated group at 2 h and 4 h (p<0.01) as illustrated in Figure 3-4B.
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Exendin-4 significantly (p<0.05) attenuated the action of cytokines, but did not
bring reporter activity back to baseline.

Counts
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Figure 3-5: Live cell imaging of the Effects of Exendin-4 on Cytokine induced Apoptosis. (A)
Representative images of the effects of exendin-4 preincubation on caspase-3 activation. Colour
bar represents photon counts/s. Cytokines cause an increase in caspase-3 reporter activity and
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exendin-4 preincubation attenuates the magnitude of that activation. (B) Quantification of 4
independent experiments as a mean ± SEM. Cytokines cause a significant increase in
bioluminescence at 2 and 4 h. The presence of exendin-4 significantly attenuates cytokine
induced activity denoted by #.

In order to confirm caspase-3 cleavage, Western blot analysis for cleaved
caspase-3 was performed on cell lysates collected at baseline, 2, 4, 6 and 12 h
following cytokine treatment (N=3).

An increase in cleaved caspase-3 was

observed over time and peaked at 6 h (Figure 3-5A). The level of caspase-3
cleavage was significant at 4 h (p<0.05) and 6 h (p<0.01) of cytokine treatment
relative to baseline (Figure 3-5B). Cleaved caspase-3 was not detected in cell
lysates treated with exendin-4.
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Figure 3-6: Western Blot Analysis of Caspase-3 cleavage by cytokines in the absence or
presence of exendin-4. Panel A shows the raw blots of cell lysates treated with cytokines in the
absence or presence of exendin-4. In the absence of exendin-4, caspase-3 cleavage increases
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and peaks at 6 h before returning to near baseline levels. Quantification of the bands is shown in
Panel B. The increase in caspase-3 cleavage is significant at 4 h but reaches maximal
accumulation at 6 h. Cleaved caspase-3 was not detected in the presence of exendin-4.

Western blot analysis of caspase-9 and BAD, elements upstream of caspase-3 in
the intrinsic pathway, was performed to determine the manner in which exendin-4
inhibits caspase-3. The blots in Figure 3-7 and 3-8 showed no appreciable
changes with cytokine treatment. In the presence of exendin-4, cleaved caspase9 was not detected. BAD was detected both in the absence and presence of
exendin-4. Quantification of cleaved caspase-9 and total BAD (Figures 3-7 & 3-8)
showed no significant changes over time.
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Figure 3-7: Western Blot analysis of the effects of exendin-4 on Caspase-9. In the absence of
exendin-4 caspase-9 and cleaved caspase-9 were detectable but no changes were observed
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over the time course. Densitometry analysis showed no significant changes in caspase-9
cleavage over the time course (bars represent Mean ± SEM). In the presence of exendin-4,
caspase-9 protein was not detected.
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Figure 3-8: Western Blot analysis of the effects of exendin-4 on BAD. The blots show that BAD
was detected in the absence and presence of exendin-4. There were no appreciable changes
over time. Densitometry analysis showed that there were no significant changes over the time
course and that there were no differences in BAD protein in the absence or presence of exendin4 (Bars represent Mean ± SEM).

Immunocytochemistry for cleaved PARP, a product of caspase-3 cleavage,
further confirmed that pro-inflammatory cytokines cause caspase-3 dependent
apoptosis. Cells in which cleaved PARP co-localized with the nucleus were
detected in both control and cytokine treated groups at 0, 2 and 4 h (Figure 39A). The percentage of cells with c-PARP co-localization were significantly higher
in control (p<0.01) and 2 h (p<0.01) cytokine treated groups compared to the 4 h
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cytokine treatment and did not differ significantly from one another (Figure 3-8D).
In the presence of exendin-4, there were no appreciable changes in the
percentage of c-PARP positive nuclei with respect to time and there were
significantly fewer c-PARP positive nuclei when compared with the cytokine
treated

group

(p<0.01)(Figure

3-9A,B,D).

Maximum

PARP cleavage was

observed at 2 h of cytokine treatment and decreased significantly at 4 h of
cytokine

treatment(p<0.05).

There

were

no

significant

changes

in

cell

morphology at either time point. Images were also collected at 24 h of cytokine
treatment in the absence of exendin-4, and there were no c-PARP positive nuclei
observed; instead, the cells displayed disrupted cell morphology, characterized
by abnormal nuclei. (Figure 3-9C)

3 .5 E x p lo rin g th e N a tu re o f C y to k in e In d u c e d A p o p to s is w ith
Im a g in g
Proinflammatory cytokines (IL-1 (3, IFN-y & TNF-a) have been shown to induce
apoptosis and caspase-3 activation in various combinations of the three. The
relative contribution of each cytokine to the final activation of caspase-3 is not
well known. I hypothesized that imaging the effect of separating out the cytokines
into their respective pathways might yield their relative contribution to apoptosis.
Transfected INS-1 cells were treated with TNF-a only, IL-ip+IFN-y or all three
cytokines and imaged for 4 h. Bioluminescence in the groups treated with IL1(3+IFN-y+TNF-a and IL-1 (3+IFN-y was significantly increased (p<0.01) when
compared with TNF-a treated cells, but IL-1 (3+IFN-y and IL-1f3+IFN-y+TNF-a did
not differ from one another.
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Figure 3-9: Immunocytochemistry for the effects of cytokines and exendin-4 on Caspase-3
substrate PARP. Panel A shows representative images of PARP cleavage in response to
cytokines in the absence of exendin-4. At control the majority of cells have c-PARP localized to
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the nucleus. After 2 h of cytokine treatment the number of c-PARP positive nuclei increases and
then decreases at 4 h. Panel B shows representative images of PARP cleavage in response to
cytokines in the presence of exendin-4. In control, 2 h treated and 4 h treated cells there are very
few cells showing c-PARP in the nucleus. In the absence and presence of exendin-4 at control, 2
h and 4 h of cytokine treatment, cells show normal nuclear morphology. Panel C shows the
effects of cytokines in the absence of exendin-4 over 24 h. C-PARP does not co-localize with the
nucleus, and all cells show disrupted nuclear morphology. Panel D shows quantification of cPARP positive nuclei under control and exendin-4 treated conditions over 4 h of cytokine
treatment.
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Figure 3-10: Bioluminescence imaging of the intrinsic and extrinsic pathway effects on caspase-3.
(A) Representative images of cytokine treated, IL-1(3+IFN-y and TNF-a only. Colour bar
represents photon counts/s. The cytokine treated cells have increased bioluminescence at 4 h
which is slightly greater than in the IL-1(3 + IFN-y treated group. TNF-a caused no change.
Quantification of bioluminescence (B) revealed that cytokines and IL-1 (3 + IFN-y significantly
increased caspase-3 activity compared to TNF-a (p<0.01) but did not differ from each other.

Changes in mitochondrial permeability precede casapse-3 activation by the
intrinsic pathway of apoptosis. I used the fluorescent mitochondrial dye JC-1,
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described in section 2.6.1, to monitor changes in mitochondrial membrane
potential. JC-1 localizes to the mitochondrial intermembrane space and forms Jaggregates at high concentrations. These J-aggregates fluoresce red and
dissociate

into

the

monomeric

form

that

fluoresces

green

upon

the

permeabilization of the mitochondrial membrane. Following a 1 h incubation in
JC-1, INS-1 cells received treatment with either TNF-a, IL-1(3+IFN-y or all 3
cytokines together, and images were collected every 20 min for 4 h. The ratio of
green to red fluorescence increased 2.5 fold in the cytokine treated group at the
end of the 4 h time course, while IL-1 p+IFN-y increased 1.26 fold. TNF-a
treatment on its own caused no change. Changes in mitochondrial permeability
of the cytokine group were significantly different from control (p<0.01), IL1(B+IFNy (p<0.01) and TNF-a (p<0.01). Mitochondrial permeability changes did
not differ significantly between control and TNF-a only and IL-1 p+IFN-y treated
groups. The data were integrated into area under the curve (AUC) plots (Figure
3-1 OB) and analyzed with Kruskal Wallis Test. The distribution of AUCs was
significantly different (p<0.05) across groups.
DNA fragmentation is a marker of end stage apoptosis. In order to confirm that
the cytokine treatments were inducing apoptosis, DNA fragmentation analysis on
samples subjected to the previously mentioned treatments for 24 h revealed
significant changes in protein concentration (p=0.049) but no differences in
fragmented DNA. When normalized to protein, no significant differences were
found when means were analyzed by One-Way ANOVA. It must be noted that
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the groups treated with Cytokines and IL-1(3+IFN-y had the highest levels of DNA
fragmentation while the TNF-a treated group had near basal levels of DNA
fragmentation (Figure 3-12) but all groups were highly variable. The distributions
of protein concentration did not differ significantly and DNA absorbance was
equal through all samples (see figure 3-12 B, C).
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Figure 3-11:

Examination of Mitochondrial

Permeability in response to various cytokine

combinations. A) Representative images of JC-1 fluorescence before and 4 h after administration
of the cytokine treatments. Ratios of Green to Red fluorescence were taken for each time course
and normalized to their baseline image, A curve was generated for each treatment, and
integrated to yield an Area Under the Curve. B) AUC quantification. Kruskal-Wallis test revealed
significant differences between groups (p<0.05) and ranked Cytokines and IL-1(3+IFN-y over
TNF-a and Control.
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0.04

Treatment

Figure 3-12: DNA Fragmentation Analysis of Cytokine Induced Apoptosis. A quantification of
absorbance readings taken at 405nm in response to a 24 h treatment with Cytokines, TNF-a and
IL-1(3 + IFN-y as a measure of DNA fragmentation. There were no significant differences found
between groups when DNA was normalized to protein concentration. Protein data (C) and DNA
data (B) were analyzed separately. There were no significant differences in protein content while
DNA content was equal.
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4 Discussion
In this study I characterized the response of the bioluminescence caspase-3
reporter, ANLucBCLuc, to various cytokine treatments in INS-1 /832/13 clonal
cells.

This was accomplished

by comparison to Western

blot analysis,

fluorescence imaging and DNA fragmentation analysis of early and terminal
events in apoptosis. The objectives of this thesis were 1) to characterise and
validate the use of ANLucBCLuc (caspase-3 reporter) as a reliable apoptosis
sensor in an in vitro T1DM cell model and 2) to elucidate the mechanisms of
caspase-3 activation in response to cytokines. I demonstrated that imaging
ANLucBCLuc activity in response to cytokines provides a highly specific and
quantitative measure of caspase-3 activity that is more sensitive than western
blot analysis. I also showed that caspase-3 activity in INS-1/832/13 cells is
transient in nature, not sustained as has been shown in other cell types and
measurement systems. With respect to the second objective I showed that
exendin-4, a known caspase-3 inhibitor, attenuated caspase-3 reporter activity.
In addition I showed that the intrinsic pathway of apoptosis is the driving force
behind (3-cell destruction by cytokines, a finding that is consistent with the
literature.
Although the use of the ANLucBCLuc caspase-3 reporter along with our imaging
system provides reliable results, there are some practical limitations to the
system. Firstly, I demonstrated a 25% transfection efficiency, a limitation that can
be overcome by selecting a stably transfected population. Secondly, the GE
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Explor Optix imaging system is not equipped with a CO 2 tank and humidity
chamber. These are necessary for maintaining a healthy cell population without
removing the cells from the Explor Optix machine. Combined with the long scan
times, and the inability to keep the cells in the Explor Optix machine, the
frequency at which images could be collected was reduced, ultimately limiting the
temporal resolution. Third and finally, integration times for each image also
decreased the temporal resolution. Ultimately, the selection of cells that stably
express the caspase-3 reporter would be the most cost effective method of
addressing all three limitations. The increased signal from increased expression
would decrease integration times for imaging and would allow for better temporal
resolution.
Bioluminescence expression systems have been previously used to monitor islet
graft survival and rejection. More specifically Chen X et al55 have transplanted
islets from a mouse expressing FLuc driven by the rat insulin promoter II into
diabetes induced mice55. They were able to detect transplanted islets and track
changes in bioluminescence as islet viability decreased. The bioluminescence
intensities were inversely correlated with changes in serum glucose over a 5 day
period55. These changes correspond to a loss in islet cell number that represents
a time point likely too late for intervention. Having an earlier marker of apoptosis
in such a scenario would be useful. To date the performance of bioluminescent
caspase-3 reporters has not been tested in a (3-cell model. The performance of
the ANLucBCLuc reporter is similar to the other bioluminescent caspase-3
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reporters that have been reported in that their activity appears transient in
response to an apoptotic stimulus46,50. Kanno et al46 have shown with their cyclic
luciferase caspase-3 reporter that the peak of bioluminescence in response to
STS is consistently around 2 h in HeLa cells expressing the reporter46. One
caveat to their reporter is that the temporal kinetics appear to be dose
dependent, as increasing doses shift the peak in bioluminescence to later time
points. This effect was noted to be strongest after treatment with potent antitumor
reagent,

actinomycin D,

with

which

a

1000

nM

dose

caused

a

peak

bioluminescence shift from 120 min to approximately 250 min as compared with
a 100 nM dose46. Coppola et al50 have demonstrated that ANLucBCLuc reaches
peak activity at approximately 4 h of treatment with TMZ with the timing being
independent of dose50. Coppola et al50 found no less than a 5-fold increase in
bioluminescence in all their treatments50 while we did not have more than a 4-fold
increase in response to cytokines. This difference is likely due to the differences
in cell type and cell toxins. My goal was to detect apoptosis in cells with an
established cytokine treatment protocol in order to establish the strength of the
reporter and imaging strategy. I was successful in this respect, as I was able to
detect caspase-3 reporter activity with cytokine treatment and reduced levels of
caspase-3 activity in the presence of the caspase-3 inhibitor exendin-4. Western
blotting showed no detectable levels of cleaved caspase-3 in the presence of
exendin-4.
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When comparing our reporter and imaging protocol with fluorescent caspase-3
reporters the major difference is the irreversible nature of the fluorescent
reporters. With the exception of the FRET based approaches, the fluorescent
reporters all relied on the translocation of a fluorophore to the nucleus after
caspase-3 cleavage39 40. A major advantage to the fluorescent reporters is that
the technology to exploit their strengths is readily available, in the form of
compound microscopes. Most importantly, these microscopes can easily be
equipped with incubation chambers for live cell imaging. As a result, they can
achieve much greater spatial resolution than with bioluminescence techniques
and can collect images more frequently. However, the properties of the
bioluminescent caspase-3 reporter construct enable a great deal of versatility in
experimental design.

4.1 Cytokines Transiently Activate Caspase-3 in INS-1/832/13
Cells
The most important and interesting finding from this study is that exposure of 0cells to cytokines induces a transient increase in caspase-3 activity.
Bioluminescence imaging quantitatively showed a transient increase in
bioluminescence that peaked within 4 h of cytokine treatment (Figure 3-3).
Western blot analysis for caspase-3 showed a transient cleavage of caspase-3
that peaked at 6 h, which was 2 h after the observed peak in bioluminescence
activity (Figure 3-6). The imaging allows the capture of changes in caspase-3
activity sooner than by Western, as it is more a measure of activity than
accumulation. The bioluminescence and Western data are in contrast to previous
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studies on the effects of cytokines in INS-1 cells. More specifically, Western blot
analysis and in vitro luciferase assays in response to treatment with cytokines
showed an increase in caspase-3 cleavage and activity that was sustained over
days or hours51'53. Inconsistencies between my results and the literature may be
due to the fact that the in vivo imaging enabled repeated imaging in the same cell
population of cells and that the INS-1/832/13 cell line is clonal. In contrast, the
cell populations used in references [51'53] are parental INS-1 cells, NIT cells and
in primary islets, which are heterogeneous populations. With respect to INS-1
cells, Collier J et al56 has demonstrated that different clones of INS-1 cells display
different responses to apoptotic stimuli and Hohmeier et al54 in their isolation of
the INS-1 832/13 clone noted that the parental INS-1 cells may in fact represent
a mixture of endocrine cells with distinct phenotypes54,56 Additionally, in previous
studies, each time point represented a sampling of a different population of cells,
resulting in a “snapshot” of caspase-3 activity at a particular time. With in vivo
imaging, I was able to measure caspase-3 activity continuously in the same cell
population. The results of these experiments may speak to the nature of not only
the INS-1/832/13 cell line but also activatable luciferase reporters. Early and
transient activation of the caspase-3 reporter was reported in the original
publication of this reporter and also with the cyclic caspase-3 luciferase reporter
in response to an apoptotic stimulus 46,50. These findings, in conjunction with
those in the present study, suggest that there is an optimal window to capture
caspase-3 activity in apoptosis that in vitro assays do not effectively capture. The
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results of my bioluminescence experiments and Westerns are consistent with the
data from the Kutlu et al3 microarray study which show an early and transient
increase in caspase-3 mRNA with cytokine treatment3.1 further confirm that
caspase-3 activation is an early event in cytokine induced apoptosis of (3-cells.
This study is the first to demonstrate the kinetics of cytokine induced caspase-3
activity in 1) a clonal (3-cell population and 2) the same cells over time.

4.2 A Short duration of Inflammation causes Caspase-3 activity
in INS-1 cells
The initiation of caspase-3 activity in response to a constant cytokine exposure
has been extensively demonstrated but the long term responses to short
exposures to cytokines have not been investigated in previous studies. My study
has shown that a 1 h pulse of cytokines induced caspase-3 activation 3 h after
the removal of cytokines (Figure 3-4). The ability of cytokines to induce caspase3 activity with such short exposures demonstrates that the initiation of apoptosis
only requires a brief initial stimulus to initiate the cascade. More importantly, it
demonstrates that an early injury to the (3-cells can result in cell death long after
the initial insult has disappeared. There have been cases reported of
spontaneous T 1DM development after infection by Enteroviruses57. The
Coxsackie B viruses in particular, have been identified as environmental risk
factors for T1DM development. Recently, a prospective study conducted on
prediabetic children 0-10 years old identified through serological studies that
enteroviral RNA was a risk factor and predictor of clinical T1DM development58.
Furthermore, a study that characterized the T-cell response to Coxsackie virus

proteins found that in chronically diabetic patients and in newly diagnosed
patients, T-cells respond by the production of IFN-y and not by proliferation59.
Interferon-y induces secretion of the chemokine IFN-y-inducible protein 10 (IP10) CXCL10, which recruits leukocytes from the blood to the site of injury. This
chemokine is increased in the serum of newly diagnosed Type 1 diabetics, and in
high risk patients when compared with normal controls, low risk patients and
patients with long standing diabetes60. This reaction to infection by the P-cell is
likely critical to the initiation of insulitis. A recent study61 demonstrated an
increase in expression of CXCL10 in human islets following treatment with IFN-y,
an effect that is reduced by exendin-461. Interestingly, there was a 700-1000 fold
increase in mRNA levels of CXCL10 in islets in response to the combination of
IL-1(B, TNF-a and IFN-y. In contrast, treatment with IFN-y alone caused a 200500 fold increase 61, suggesting a synergism in the actions of the cytokines.
Since the development of T1DM is linked to caspase-3-dependent apoptosis 15,
the production of IFN-y by T-cells in response to pancreatic viral infection and
increased secretion of CXCL10 may be the critical steps in priming the immune
system with (3-cell antigens and initiating insulitis development. My results taken
within this context thus suggest that in an in vivo setting, a brief insult that causes
a reaction with pro-inflammatory cytokines may be sufficient to initiate insulitis. In
order to further explore this mechanism, a transgenic mouse expressing the
ANLucBCLuc construct in (3-cells and our imaging set up would be an excellent
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way to monitor disease progression after infection and clearance of
enteroviruses.

4.3 The Role of Exendin-4 in Protection against Cytokine
induced Apoptosis
In an effort to test the responses of the bioluminescent caspase-3 reporter and of
proteins upstream of caspase-3 in the intrinsic apoptotic pathway to GLP1/exendin-4, INS-1/832/13 cells were treated with cytokines in the absence or
presence of exendin-4. Exendin-4 significantly reduced reporter activity in the
presence of cytokines (Figure 3-5). Western blot analysis of caspase-3 (Figure 36) showed a time dependent increase in caspase-3 cleavage in response to
cytokines, but no caspase-3 cleavage was observed in the presence of exendin4. This result clearly demonstrates the strength of the imaging system as it can
easily capture changes in caspase-3 activity after treatment with exendin-4 that
are not apparent by Western blot analysis. Previous studies have shown by
fluorometric assays that exendin-4 and GLP-1 decrease caspase-3 activity62.
Tews et al62 reported a 30% reduction in caspase-3 activity after a 5 h exposure
to exendin-4 and a 22 h cytokine exposure62. The magnitude of the reduction in
caspase-3 activity by exendin-4 in their study is similar to my observations,
further solidifying the validity of this method. Imaging and fluorometric caspase-3
assays demonstrate their strengths over Western blot analysis because their
dependence on enzymatic activity is independent of antibody immunoreactivity
and they are quantitative measures. This provides a high level of consistency in
measurement and increased sensitivity to subtle changes ine caspase-3 activity.
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Both techniques are highly sensitive, but the advantage of our imaging technique
over the fluorometric assay is the ability to repeatedly image the same population
of cells and the ability to keep the cells intact. With this experiment I
demonstrated the strength of the reporter because of its high sensitivity to
changes in caspase-3 activity even in the presence of a known caspase-3
inhibitor.
Since I was able to demonstrate that the caspase-3 reporter could detect the
effects of exendin-4 on caspase-3 activity, I next investigated the time course of
changes of other components of the intrinsic pathway of apoptosis. Caspase-9
cleavage immediately precedes caspase-3 cleavage in the intrinsic pathway.
However, I did not find significant changes with respect to time in the generation
cleaved caspase-9, even after a 12 h cytokine exposure (Figure 3-7). This result
is in contrast to Grunnet et al’s51 study in 2009 that reported a significant
cleavage of caspase-9 after 12 h and 24 h of cytokine exposure in parental INS-1
cells and isolated islets 51. Both these cell populations, as previously discussed
are heterogeneous cell populations and could have an effect on the observed
differences in response. In the presence of exendin-4 neither cleaved nor full
caspase-9 were observed. This result is consistent with the effects that exendin4/GLP-1 has on reducing caspase-9 activity and expression26 63.
The protein BAD is also a component of the intrinsic pathway that acts upstream
of caspase-3 (Figure 1-1). It acts as a switch between apoptosis and survival
based on its phosphorylation state. Dephosphorylation of BAD precedes changes

in mitochondrial permeability, and is essential for the formation of the
mitochondrial pore that results in the release of cytochome c into the cytosol. I
found no significant changes in total BAD protein in response to cytokine
treatment. Exendin-4 had no significant effect on total BAD expression (Figure 38). An examination of the phosphorylation state of BAD would have yielded
important information with respect to the mechanism of exendin-4/GLP-1
regulation of apoptosis in [3-cells. Three phosphorylation sites have been
identified on BAD, Serine (Ser) 112, Ser136 and Ser155. Each of these sites is
preferentially phosphorylated by a specifc kinase. S eri 55 is preferentially
phosphorylated by Protein Kinase A (PKA), Ser136 by PKB/Akt and S eri 12 by
MAP Kinase Activating Protein-Kinase 164. Exendin-4/GLP-1 has been shown to
induce BAD phosphorylation at Ser13651 and S eri 1265. It is likely that GLP1/exendin-4 causes phosphorylation at Ser155 since they have been shown to
initiate insulin secretion in a cAMP/PKA dependent manner66,67.The failure to
detect changes in the proteins upstream of caspase-3 in the intrinsic pathway by
Western blot, or changes in caspase-3 cleavage after preincubation with
exendin-4 demonstrates the limits of sensitivity of the antibodies in question. On
top of the technical limitations, cell type differences may contribute to this
response. Collier J et al56 compared INS-1/832/13 cells with a cytokine resistant
clone (833/15) derived from the same parental population, and showed that the
cytokine resistant clones are equally susceptible to chemical apoptosis inducing
agents56. They also investigated the role of the proapoptotic Bcl-2 proteins Bax

64

and Bak, which act downstream of BAD. They found that these proteins regulate
chemically induced apoptosis in 832/13 cells; but silencing them does not protect
832/13 cells from cytokine induced toxicity56. Previous work from the same group
showed that over expression of the anti apoptotic protein, Bcl-2, did not confer
protection against cytokine induced apoptosis68.
I next examined the effects of cytokines on events downstream of caspase-3
activation. Poly(ADP)-ribose polymerase, or PARP, is a nuclear substrate of
caspase-3. Using immunocytochemistry (ICC), I examined nuclear localization of
cleaved PARP in the presence of cytokines with or without exendin-4.
Unexpectedly, the ICC results showed high basal levels of cleaved PARP which
then decreased by 4 h. The role of full length PARP is to repair DNA damage, a
process that depletes cellular NAD+69. Cleavage of PARP slows down the
depletion of NAD+, effectively reducing cell metabolism and leaving an energy
reserve for apoptosis. It was shown by Burkart et al70 that PARP'/_ and PARP+/'
mice are resistant to P-cell destruction by STZ. They showed that STZ treatment
does not deplete NAD+ content in PARP'/_ or PARP+/' islets and the PARP'/_ islets
are equally as susceptible to DNA fragmentation as the PARP+/+ islets70. This
result in conjunction with the findings of Boulares et a l 14 that caspase-3 resistant
PARP mutants are more susceptible to cell death, shows that PARP cleavage
may not necessarily be a hallmark of cell death but rather a marker of NAD+
depletion. Studies have shown that PARP is ubiquitously cleaved by caspase-3,
but also that it is dispensable for apoptosis. Caspase-7 has been shown to

cleave PARP in a cell free system in the absence of caspase-371. With this
redundancy between caspase-3 and caspase-7 with respect to PARP, it is
possible that caspase-7 may be responsible for the high levels of basal cleaved
PARP. Overall our experiments show a protection from apoptosis at the level of
the post translational cleavage of caspase-3, and at the level of caspase-9
expression.

4.4 Cytokines Induce Intrinsic Apoptosis
Apoptosis induced by the combination of IL-ip, IFN-y and TNF-a likely occurs via
activation of both the intrinsic and extrinsic pathways. Using our caspase-3
reporter, I was able to show that the peak of caspase-3 activity is a result largely
of the actions of IL-1 (3 and IFN-y, and therefore of the intrinsic pathway of
apoptosis. It has recently been shown that IL-1 (3 and IFN-y induce apoptosis
through the intrinsic pathway in 3-cells51. TNF-a has not been shown to cause
apoptosis in P-cells on its own. The transcriptional and splicing networks of Pcells that are regulated by IL-1 p and TNF-a in combination with IFN-y, have been
elucidated by a recent microarray study72. This study found that IL-13 and TNF-a
have similar effects with respect to genes that regulate inflammation and cause a
decrease in the expression of incretin hormone receptors including the GLP-1
receptor72. In the current literature, IFN-y enhances the actions of IL-1 p and TNFa. Suk. K et al9 showed that IFN-y and TNF-a are equally effective at reducing
cell viability as IL-1 p and IFN-y and that this combination induces significant
caspase-3 and 8 like activity in MIN6N8 cells9. My results in examining the
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effects of cytokines on mitochondrial membrane permeability suggest incomplete
membrane uncoupling. The mitochondrial permeability images illustrate an
important point that echoe findings from Bossy-Wetzel, E. et al73, that cytokines
do not cause complete uncoupling of the mitochondrial membrane73. More
specifically it was found that cytochrome c release from the mitochondrial
intermembrane space occurrs independently of mitochondrial membrane
depolarization73. A similar result was found by Chang I et al74 with IFN-y + TNF-a
treatment, where they showed increases in cytosolic cytochrome c, but no
corresponding change in mitochondrial permeability before 72 h74. Chang74 and
Suk’s9 results with IFN-y and TNF-a synergism illustrate a new avenue that could
be further studied with our imaging system and technique, as both studies
demonstrated cleavage of caspase-3 after 36 h and 24 h of IFN-y and TNF-a
treatment respectively. The notion of IFN-y and TNF-a synergism is worth
exploring further with our imaging system as it is more readily quantifiable than
traditional biochemical techniques. A direct quantitative comparison between
these two combinations and any other combination of cytokines could easily be
made within hours of cytokine treatment. With this imaging system we could
determine whether IFN-y/TNF-a synergism plays a significant role in the early
induction of caspase-3 activity.

4.5 Future Directions
One of the more interesting results from my work is the potential of the caspase3-luciferase construct to image IFN-y/TNF-a synergism. In order to follow up
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these results, I could investigate caspase-3 activation with TNF-a in the presence
of either IFN-y or IL-113. I would expect to find greater levels of caspase-3 activity
with TNF-a/IFN-y than with TN F-a/IL-ip because of IFN-y’s ability to inhibit the
cells ER stress defense mechanisms8. From those results I would conclude that
IFN-y is essential to the initiation of cytokine induced (3-cell apoptosis.
I could also explore the effects of other inducers of apoptosis in (3-cells, such as
STZ,

high glucose and high fatty acids, on caspase-3 activity. I would

characterize the response of the caspase-3 reporter to STZ, high glucose and
fatty acids by treating cells with doses known to cause apoptosis, and image
reporter activity. After having established a time for maximal caspase-3 activity I
would explore the effects of glucose and fatty acids together. I would expect
glucose and fatty acids to induce caspase-3 reporter activity after prolonged
exposure separately and that the magnitude of the activation would not differ.
When cells are incubated with high glucose and fatty acids together I would
expect a reduction in the exposure time required to induce caspase-3 reporter
activity. From those results I could conclude that the combination of high free
fatty acids and hyperglycemia accelerates (3-cell apoptosis and contributes
significantly to T2DM pathology.
Going beyond the cellular response, a transgenic mouse expressing the
ANLucBCLuc reporter in the (3-cells could be generated and used to explore islet
transplant apoptosis and, additionally, in vivo detection of endogenous islet
apoptosis under various models of diabetes pathology. If a transgenic mouse
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were to be made we could make a quick assessment of islet health after isolation
and transplant the islets into diabetic mice. Following transplantation islet health
can be monitored by imaging, and if the reporter indicates poor islet health,
intervention that improves islet survival can be applied. These experiments would
also provide valuable information regarding when islets are most susceptible to
cell death during the isolation and transplantation. I believe this reporter construct
would be useful in monitoring T1DM and T2DM pathology in vivo. In order to
investigate T 1DM pathology in vivo, a well established model of diabetes would
be required. The STZ model could be applied to the transgenic mouse and
imaging would be carried out before, immediately after, and daily or weekly until
signs of overt diabetes are apparent. This would yield important information with
respect to the nature of islet loss under the STZ model. Once this model is well
understood, the same techniques could be applied to spontaneous models of
T1DM and T2DM.

5 Conclusions
The objectives of this thesis were to demonstrate the efficacy of in vivo imaging
of caspase-3 in a type 1 diabetes cell model, and to elucidate the mechanism of
caspase-3 activation in the early stages of apoptosis. With respect to imaging, I
was successful in both objectives, as I was able to quantitatively assess the level
of caspase-3 activity in response to pro inflammatory cytokines, and found that
the caspase-3 response is transient in INS-1 /832/13 cells. I was also able to
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demonstrate that the intrinsic pathway activates caspase-3 early on, although
details of the mechanism remain unclear.
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